Cormorant Asset Management, LP Agenus Inc Transaction History

Cormorant Asset Management, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.92 - $5.74 $14 Million - $27.6 Million	-4,807,557 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$2.56 - $5.49 $7.53 Million - $16.2 Million	-2,942,443 Reduced 37.97%	4,807,557 $26.4 Million
Q1 2021 May 17, 2021	BUY	$2.69 - $5.25 $2.02 Million - $3.94 Million	750,000 Added 10.71%	7,750,000 $21.1 Million
Q4 2020 Feb 16, 2021	SELL	$3.17 - $4.49 $4.76 Million - $6.74 Million	-1,500,000 Reduced 17.65%	7,000,000 $22.3 Million
Q3 2020 Nov 16, 2020	SELL	$2.98 - $5.2 $7.45 Million - $13 Million	-2,500,000 Reduced 22.73%	8,500,000 $34 Million

Q2 2020 Aug 14, 2020	SELL	$2.29 - $4.24 $2.69 Million - $4.98 Million	-1,174,486 Reduced 9.65%	11,000,000 $43.2 Million
Q1 2020 May 15, 2020	BUY	$1.92 - $4.39 $23.4 Million - $53.4 Million	12,174,486 New	12,174,486 $29.8 Million

128

205M

1.18M

69.8K

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.74B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Cormorant Asset Management, LP with notifications on news.